Avidity Biosciences
RNA
#1843
Rank
NZ$18.77 B
Marketcap
NZ$124.59
Share price
-0.19%
Change (1 day)
122.54%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: NZ$18.77 Billion

As of December 2025 Avidity Biosciences has a market cap of NZ$18.77 Billion. This makes Avidity Biosciences the world's 1843th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$18.77 B194.71%
2024NZ$6.36 B462.18%
2023NZ$1.13 B-51.22%
2022NZ$2.32 B42.33%
2021NZ$1.63 B22.96%
2020NZ$1.32 B

End of Day market cap according to different sources

On Dec 21st, 2025 the market cap of Avidity Biosciences was reported to be:

NZ$18.80 Billion
by Nasdaq info icon info icon
NZ$18.80 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
NZ$10.93 B-41.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.41 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$3.83 B-79.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$5.15 B-72.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.20 B-98.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$18.86 B 0.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$247.34 B 1,217.58%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$169.78 B 804.45%๐Ÿ‡ฌ๐Ÿ‡ง UK